Moderator, Antitrust Section - Health Care and Pharmaceuticals, American Bar Association
Intellectual Property Report
ABA's Antitrust Magazine
The FDA’s and FTC’s Increased Focus on Generic Drug Competition Signals Enhanced Attention to REMS IssuesExternal Article
ABA’s Antitrust Health Care Chronicle
Moderator, Platform Regulation and Antitrust
Baker Botts will host a comprehensive CLE program in our Washington office on October 24, 2017.